Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 18591-18600 Newer>

The Motley Fool November 21, 2006 Seth Jayson	More Pumping for Manchester Any investors out there think Blue Chip IR has your financial well-being in mind when it shells out $50K to pump an overpriced acquisition machine in the used car biz?
The Motley Fool November 21, 2006 Rich Smith	Career Education Cuts Bait CEC was expected to report $452 million in revenues and $0.29 per share in profits. As it turned out, the firm fell a few cents short of its profits target. Investors, take note.
The Motley Fool November 21, 2006 Rick Aristotle Munarriz	Games Kings Play Burger King wants to play Xbox 360 video games with you this holiday season. So who will get the most out of this relationship, the fast-food restaurant or Microsoft? Investors, take note.
The Motley Fool November 20, 2006 Todd Wenning	Yes, You Can Beat the Market How do individual investors have the upper hand against fund managers? As an individual investor, you have mobility and freedom on your side -- something mutual fund managers don't always have.
The Motley Fool November 20, 2006 Brian Lawler	One-and-a-Half Setbacks for Exelixis Drug development is a long process usually involving many setbacks and failures, even for the most successful drug makers. Investors in this biotech shouldn't worry too much about this one.
The Motley Fool November 20, 2006 David Lee Smith	Schlumberger: Crude Resistance? Falling oil prices don't spell disaster for the energy services firm. Investors, take note.
The Motley Fool November 20, 2006 Steven Mallas	Smucker's Earnings Jam JM Smucker's jams hit the spot, but its earnings missed the mark. All the same, investors interested in growing free cash flow might want to give Smucker a taste test.
The Motley Fool November 20, 2006 Seth Jayson	Ann Goes Tumbling Shares of Ann Taylor drop on a recent earnings report. Have they fallen far enough for investors to purchase shares?
The Motley Fool November 20, 2006 Brian Gorman	Hospira's Bold Move The drug delivery outfit's stab at biosimilars is worth some attention, but investors shouldn't assume a major payoff.
The Motley Fool November 20, 2006 Ryan Fuhrmann	Slower Going at Lowe's Does short-term pain at Lowe's open the doorway to long-term opportunities for investors?
<Older 18591-18600 Newer> Return to current articles.